Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inspectis is a Swedish company that designs, manufactures, and sells professional digital microscopes, video capillaroscopy systems, and associated software. The company serves both industrial inspection markets and healthcare-oriented capillaroscopy applications, including non-invasive assessment of microcirculation abnormalities relevant to rheumatic diseases such as systemic sclerosis and Raynaud’s phenomenon. Its offerings include 4K and Full HD digital optical inspection systems, image analysis and metrology software, and dedicated capillaroscopy products for clinical use. Inspectis manufactures in Sweden, distributes globally through partners and resellers, and operates under ISO 13485 and ISO 9001 quality management certifications. Overall, it appears to be a commercial-stage optical systems and medical/diagnostic device company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inspectis.